| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.69▼ | 8.69▼ | 8.69▼ | 8.67▼ | 10.08▼ |
| MA10 | 8.60▲ | 8.64▲ | 8.65▲ | 9.09▼ | 9.59▼ |
| MA20 | 8.62▲ | 8.65▲ | 8.72▼ | 9.86▼ | 8.61▲ |
| MA50 | 8.79▼ | 8.96▼ | 9.31▼ | 9.18▼ | N/A |
| MA100 | 9.09▼ | 9.77▼ | 9.97▼ | 8.55▲ | N/A |
| MA200 | 9.91▼ | 10.03▼ | 9.82▼ | 8.30▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.023▲ | 0.035▲ | 0.049▲ | -0.250▼ | 0.096▲ |
| RSI | 49.438▼ | 46.299▼ | 43.957▼ | 41.100▼ | 49.143▼ |
| STOCH | 59.714 | 64.088 | 64.870 | 11.834▼ | 73.942 |
| WILL %R | -43.333 | -23.214▲ | -31.200 | -89.067▼ | -56.706 |
| CCI | 29.167 | 33.613 | 28.073 | -68.735 | -1.499 |
|
Monday, June 16, 2025 05:52 AM
The Russell 3000® Index tracks the performance of the largest 3,000 publicly traded U.S. companies and serves as a broad benchmark for the U.S. equity market. The Russell 2000® Index, a subset of the ...
|
|
Monday, June 02, 2025 09:00 AM
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company’s lead product candidate is elraglusib ...
|
|
Saturday, May 31, 2025 05:26 PM
Actuate Therapeutics, Inc. (NASDAQ:ACTU) has announced breakthrough results from its Phase 2 trial of elraglusib combined with gemcitabine/nab-paclitaxel (GnP) in previously untreated metastatic ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 8.63 | 9.005 | 8.60 | 8.65 | 26,200 |
| 12/06/25 | 8.54 | 9.248 | 8.24 | 8.61 | 59,500 |
| 11/06/25 | 8.66 | 8.817 | 8.32 | 8.67 | 19,900 |
| 10/06/25 | 8.80 | 8.865 | 8.72 | 8.72 | 9,718 |
| 09/06/25 | 9.095 | 9.35 | 8.65 | 8.71 | 35,800 |
| 06/06/25 | 9.20 | 9.35 | 8.87 | 8.96 | 36,700 |
| 05/06/25 | 9.13 | 9.33 | 8.37 | 9.09 | 59,600 |
| 04/06/25 | 9.98 | 9.98 | 9.08 | 9.11 | 63,307 |
| 03/06/25 | 10.90 | 10.90 | 9.75 | 9.75 | 88,403 |
| 02/06/25 | 11.70 | 11.70 | 9.3584 | 10.59 | 171,124 |
|
|
||||
|
|
||||
|
|